Ask AI
Brad Kahl

Brad Kahl, MD

Professor of Medicine
Washington University in St. Louis
Director, Lymphoma Program
Siteman Cancer Center
St. Louis, Missouri

Explore Activities by Brad Kahl

Title
Format
Credit Type
Credits
Congress to Clinic: Clinical Advances Journal Club on Emerging CAR T-Cell Therapy Data From Summer Conferences ASCO, EHA, and ICML

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
CAR T-Cell Therapy Updates: Key Highlights From Recent Conferences & Answers to Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Interactive Treatment Decision Tool for MCL: A US Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Emerging CAR T-Cell Therapy Data for Lymphomas and Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Precision Choices in CLL: Tailoring Treatment Strategies Across Disease Stages

Content Format:

Clinical Thought

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25
FAQs: Expert Perspectives on Treatment Decision-making for Patients with CLL/SLL Based on the Latest Evidence

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

1.50
Applying New Advances in Frontline CLL/SLL Therapy: Aligning Clinical Evidence With Current NCCN Guidelines and Expert Recommendations

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimizing Frontline Therapy for Mantle Cell Lymphoma: The Evolving Role of BTK Inhibitors

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.75
BTK Inhibitors for Mantle Cell Lymphoma: Overview and Current Treatment Landscape

Content Format:

Slideset

Credit Type:

--

Credits:

--
Practical Guidance for the Multidisciplinary Team on Therapeutics Targeting Protein Degradation Pathways in NHL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Applying Data to Practice: BTK Inhibitor Therapies to Treat CLL and MCL

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
FAQs: Current and Emerging Roles of BTK Inhibitors in MCL

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors

Content Format:

Slideset

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors

Content Format:

Video

Credit Type:

ABIM MOC | ACPE | AMA | ANCC

Credits:

1.00
2023 Global Conference Coverage Updates on BTK Inhibitors for CLL and MCL

Content Format:

Slideset

Credit Type:

--

Credits:

--